Skip to main content
SUZ
NYSE Manufacturing

Suzano 2Q26: EBITDA Falls 23% YoY, Leverage Rises to 3.4x, Kimberly-Clark JV Closes

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
7
Price
$8.06
Mkt Cap
$9.965B
52W Low
$7.555
52W High
$11.535
52W Position info
6.7% above low
Off High info
30% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

SUZ is trading near its 52-week low of $7.555 (6.7% above the low) on elevated volume (1.8× avg).

Summary

Suzano reported 2Q26 Adjusted EBITDA of R$4.7 billion, down 23% YoY, with net income down 64% to R$1.8 billion. Leverage rose to 3.4x, but free cash flow improved to R$3.3 billion. The company also confirmed completion of its US$1.3 billion Kimberly-Clark JV acquisition.


Key Events · Earnings and Guidance · SUZ

  • 2Q26 Adjusted EBITDA Falls 23% YoY

    Adjusted EBITDA was R$4.7 billion, down 23% from R$6.1 billion in 2Q25, driven by FX depreciation, lower pulp sales volumes, and higher cash costs.

  • Net Income Down 64% YoY

    Net income was R$1,807 million, down from R$5,012 million in 2Q25, primarily due to a lower financial result and higher COGS.

  • Leverage Rises to 3.4x

    US$ net debt/Adjusted EBITDA increased to 3.4x from 3.1x a year ago, reflecting lower trailing EBITDA. Net debt was US$12.8 billion.

  • Adjusted Free Cash Flow Improves

    Adjusted Free Cash Flow was R$3.3 billion, up 27% YoY, driven by working capital release and positive derivative cash settlements.


Analysis · SUZ · Manufacturing

Suzano's second-quarter results show a sharp year-over-year decline in profitability, with Adjusted EBITDA down 23% to R$4.7 billion and net income down 64% to R$1.8 billion. The company's US$ leverage ratio climbed to 3.4x from 3.1x a year ago, reflecting weaker trailing EBITDA. However, Adjusted Free Cash Flow improved 27% YoY to R$3.3 billion, and the company completed its US$1.3 billion acquisition of a 51% stake in the Kimberly-Clark tissue joint venture on July 1, 2026. The earnings release also confirms the company's guidance for 2026 pulp cash cost at approximately R$800/t and net debt/leverage targets of US$11.0 billion and below 2.5x for 2027-2028.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SUZ was trading at $8.06 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10B. The 52-week trading range was $7.56 to $11.54. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SUZ - Latest Insights

SUZ
Nov 05, 2026, 6:23 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $9.39
Real-time Price: $9.26 info
Change: -$0.130 (-1%) info
Market Cap: $11.807B info
SUZ
Nov 05, 2026, 4:38 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $9.26 info
Change: -$0.240 (-3%) info
Market Cap: $11.807B info
SUZ
Nov 05, 2026, 4:37 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $9.26 info
Change: -$0.240 (-3%) info
Market Cap: $11.807B info
SUZ
Aug 24, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $9.07
Real-time Price: $9.26 info
Change: +$0.190 (+2%) info
Market Cap: $11.807B info
SUZ
Jul 01, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $7.59
Real-time Price: $9.26 info
Change: +$1.67 (+22%) info
Market Cap: $11.807B info